Equity in Precision Medicine Award – Project Submission

The Equity in Precision Medicine Award recognises initiatives that identify and meaningfully address disparities in access to precision oncology for children with cancer. It asks which children are still unable to benefit and why, then supports a purposeful intervention to close that gap. The focus is actual inclusion of a defined underserved population, not simply wider availability of a service.

• Every application must include at least one current PHO Chapter member in good standing with a substantive role in identifying the equity gap, designing/implementing the intervention and/or evaluating impact.
• Eligible collaborators may include healthcare institutions, patient-support organisations, foundations, civil-society organisations, public-health/government partners, philanthropic partners, professional groups and other relevant stakeholders.
• A non-PHO partner may initiate a proposal only after identifying and establishing meaningful collaboration with an eligible PHO member before submission.
• The application must define a specific underserved population and a specific barrier; a general statement that access is poor is insufficient.
• The proposed intervention must be designed to overcome that barrier and include measurable patient/population-level equity outcomes.
• The model should be sustainable beyond one-time assistance and have potential for replication or institutional integration.
• Projects involving patients or patient data require appropriate institutional and Ethics Committee approvals where applicable.